Emergent BioSolutions (EBS) files $100M Mixed Securities Shelf Registration
More News related to EBS
- Former U.K. Health Protection Agency Director Rejoins Emergent BioSolutions to Head Biodefense Business
- Emergent BioSolutions to Webcast Presentations at Upcoming Investor Conferences
- Emergent BioSolutions (EBS) Acquires MdBio Foundation Facility and Land for $8.2M
- Emergent BioSolutions Enhances Manufacturing Infrastructure with Strategic Acquisition in Baltimore
- Emergent Biosolutions (EBS) Misses Q3 EPS by 4c, Reaffirms
More News related to Equity Offerings
- Xerox (XRX) Closes $2B Unsecured Senior Note Offering
- American Water Works (AWK) Closes $60M Debt Offering
- ZIOPHARM Oncology (ZIOP) Prices 15.5M Common and 7.74M Warrant Offering at $3.10/Unit
- Regency Centers (REG) Prices 8M Common Offering at $30.75/Share
- Western Gas (WES) Prices 6M Common Unit Offering at $18.20/Unit
Emergent BioSolutions Inc. (NYSE: EBS) filed with the U.S. Securities and Exchange Commission (SEC) a universal shelf registration statement which, when declared effective, will permit the company to issue up to an aggregate of $100 million of common stock, preferred stock, debt securities and warrants.
Related Categories
Equity OfferingsStocks Mentioned
-0.04Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
